P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA (CITADEL-112): PRELIMINARY SAFETY RESULTS
| Autor: | J.-M. Sancho, A. Lopez-Guillermo, P. Abrisqueta, A. Kumar, R. Cordoba, M. Tani, W. Zhao, E. Rappold, P. Langmuir, M. Mims |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | HemaSphere, Vol 6, Pp 992-993 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2572-9241 |
| DOI: | 10.1097/01.HS9.0000847276.06711.b7 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text